Area of research
Oncology · Cancer Research
Research interest
Research interests include Medicine, Head and neck, Head and neck cancer, Larynx, Occult, and Pharynx.
NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study)
Phase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5‐fluorouracil or carboplatin/paclitaxel for first‐line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck
Head and Neck Cancers, Version 1.2015
Head and Neck Cancers, Version 2.2014
Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
Randomized Phase III Study of Erlotinib Versus Observation in Patients With No Evidence of Disease Progression After First-Line Platin-Based Chemotherapy for Ovarian Carcinoma: A European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup Study